We recently compiled a list of the 14 Best Large Cap Dividend Growth Stocks To Buy Now. In this article, we are going to take ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on UnitedHealth (UNH – Research Report) and Eli ...

In a report released today, Geoff Meacham from Citi maintained a Buy rating on Eli Lilly & Co (LLY – Research Report). The company’s shares ...

Maddi Reese is asked to remix one thing about each of her castmates from Southern Hospitality. She says she would get Emmy Sharrett some waterproof mascara, find a love partner for TJ Dinch so he ...

The increased popularity of football has contributed to the Super Bowl becoming the spectacle that it is today. Memorable, ...

Reebok honors one of their most iconic sneakers with a special edition release The post Reebok celebrates big with new ...

Eli Lilly is set to report fourth-quarter earnings early Thursday, with analysts expecting rising sales and profit in the first full quarter with the company's weight-loss drugs no longer in shortage.

LabConnect, a leading provider of central lab services and functional service provider solutions, is proud to announce the ...

We recently published an article titled Jim Cramer’s Game Plan: 15 Stocks in Focus. In this article, we are going to take a ...

Stocks swung lower Friday after the White House confirmed it will impose tariffs on Mexico, Canada and China beginning ...

Many Americans support prohibiting commercials for prescription drugs on television. But enacting that ban could be complicated.

With its offering of tirzepatide (branded as Mounjaro and Zepbound), Eli Lilly and Co. (NYSE: LLY) was another key pharma player in this new type of treatment for diabetes and obesity.